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Summary
 
A panel of monoclonal antibodies was raised from mice immunized with a membrane prepara-
tion from 
 
Entamoeba histolytica
 
, the pathogenic species causing invasive amebiasis in humans.
Antibody EH5 gave a polydisperse band in immunoblots from membrane preparations from
different 
 
E. histolytica
 
 strains, and a much weaker signal from two strains of the nonpathogenic
species 
 
Entamoeba dispar.
 
 Although the exact chemical structure of the EH5 antigen is not yet
known, the ability of the antigen to be metabolically radiolabeled with [
 
32
 
P]phosphate or
[
 
3
 
H]glucose, its sensitivity to digestion by mild acid and phosphatidylinositol-specific phospho-
lipase C, and its specific extraction from 
 
E. histolytica
 
 trophozoites by a method used to prepare
lipophosphoglycans from 
 
Leishmania
 
 showed that it could be classified as an amebal lipophos-
phoglycan. Confocal immunofluorescence and immunogold labeling of trophozoites localized
the antigen on the outer face of the plasma membrane and on the inner face of internal vesicle
membranes. Antibody EH5 strongly agglutinated amebas in a similar way to concanavalin A
(Con A), and Con A bound to immunoaffinity-purified EH5 antigen. Therefore, surface lipo-
phosphoglycans may play an important role in the preferential agglutination of pathogenic
amebas by Con A. The protective ability of antibody EH5 was tested in a passive immunization
experiment in a severe combined immunodeficient (SCID) mouse model. Intrahepatic chal-
lenge of animals after administration of an isotype-matched control antibody or without treat-
ment led to the development of a liver abscess in all cases, whereas 11 out of 12 animals immunized
with the EH5 antibody developed no liver abscess. Our results demonstrate the importance
and, for the first time, the protective capacity of glycan antigens on the surface of the amebas.
 
T
 
he intestinal parasite 
 
Entamoeba histolytica
 
 is a major
cause of human morbidity and mortality, claiming up
to 100,000 victims every year (1). 
 
Entamoeba dispar
 
 is its
nonpathogenic counterpart, morphologically very similar,
but defined as a separate species (2). The molecules on the
surface of the amebas have been studied extensively be-
cause they interact with the human host and also represent
possible vaccine candidates. In 1991, Espinosa-Cantellano
and Martinez-Palomo reviewed the characterization of a
number of surface proteins of 
 
E. histolytica
 
 (3), the most im-
portant being the galactose- and 
 
N
 
-acetylgalactosamine–
inhibitable lectin (4–6), which the amebas use to adhere to
host cells and other target structures. Since then more data
about the structure (for example see reference 7) and func-
tional properties (reference 8) of known surface proteins
have been obtained, and more surface proteins have been
described (9, 10). The galactose- and 
 
N
 
-acetylgalac-
tosamine–inhibitable lectin (11–13), as well as the serine-
rich surface protein (14) and the 29-kD putative surface an-
tigen (15), were suggested as vaccine candidates and were
tested in rodent models.
Lipophosphoglycan antigens from 
 
E. histolytica
 
 were de-
scribed for the first time by Isibasi et al. (16), and later
monoclonal antibodies (17–20) have been used to study
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their expression under different culture conditions (21) and
in different 
 
E. histolytica
 
 strains (22). One antibody against
lipophosphoglycans was able to inhibit adhesion of amebas
to target cells and cytotoxicity (20). Recently, the expres-
sion of lipophosphoglycans was correlated to amebic viru-
lence (23).
In this report we describe a new antibody, EH5, that
preferentially bound to 
 
E. histolytica
 
 strains and much less to
 
E. dispar.
 
 We demonstrated that the EH5 antigen was a lipo-
phosphoglycan and for the first time localized the antigen
on the outer face of the plasma membrane and the inner face
of internal vesicles by confocal immunofluorescence and im-
munoelectron microscopy. The immunoaffinity-purified an-
tigen bound to Con A and may be important for the effect
of agglutination of 
 
E. histolytica
 
 by Con A. The EH5 anti-
body significantly protected SCID mice against intrahepatic
challenge with 
 
E. histolytica.
 
 Taking all this together, we
show that lipophosphoglycans are major protective anti-
gens on the surface of pathogenic amebas.
 
Materials and Methods
 
Strains and Growth Conditions.
 
Trophozoites of the pathogenic
 
E. histolytica
 
 strains SFL-3, HM-1:IMSS, 200:NIH, and HK-9
were cultured axenically at 37
 
8
 
C in TYI-S-33 medium (24). 
 
E.
dispar
 
 strain SAW760 (25) was maintained monoxenically in
TYI-S-33 with 
 
Crithidia fasciculata
 
, and for the experiments the
 
Crithidiae
 
 were omitted. The 
 
E. dispar
 
 strain SAW142 was cul-
tured xenically in TYSGM-9 medium (26). 
 
E. histolytica
 
 strain
SFL-3 was also cultured xenically in Robinson medium (27). 
 
Tri-
chomonas vaginalis
 
 strain 30001 (American Type Culture Collec-
tion, Rockville, MD) was grown in TYM medium (28) supple-
mented with 5% (vol/vol) heat-inactivated horse serum and
0.05% (wt/vol) agar.
 
Membrane Antigen Preparation.
 
Membrane antigens were pre-
pared as described by Ramwani and Mishra (29). In brief, tro-
phozoites were harvested by centrifugation, washed three times
with 150 mM NaCl, and finally resuspended in 100 mM sodium
phosphate, 1 mM EDTA, and 5 mM iodoacetamide, pH 7.2.
The trophozoites were homogenized by 30 strokes in a Dounce
homogenizer, and debris was precipitated by centrifugation at
700 
 
g
 
 for 10 min at 4
 
8
 
C and discarded. Membrane antigens were
precipitated by ultracentrifugation at 100,000 
 
g
 
 at 4
 
8
 
C for 1 h and
resuspended in distilled water or the desired buffer.
 
Immunization of Mice and Antibody Production.
 
Four female
BALB/c mice (Forschungsinstitut für Versuchstierzucht, Himberg,
Austria) were immunized intraperitoneally starting at the age of 8
wk. For the initial dose, 50–75 
 
m
 
g membrane preparation (29)
from 
 
E. histolytica
 
 strain SFL-3 in 150 
 
m
 
l of 0.9% (wt/vol) NaCl
was mixed with 150 
 
m
 
l of complete Freund’s adjuvant. On days
27 and 35, animals received the same amount of membrane prep-
aration in incomplete Freund’s adjuvant. The antibody response
was assayed by ELISA as described below. 3 d before the fusion,
mice received an intravenous injection of 100 
 
m
 
l, and 1 d later an
injection of 50 
 
m
 
l of amebic membrane antigen in PBS (0.5 
 
m
 
g/
 
m
 
l). 2 d later, the mouse with the highest ELISA titer was killed,
and splenocytes were isolated and fused to P3-X-Ag8.653X my-
eloma cells at a ratio of 5:1 by standard polyethylene glycol
method (30, 31). Hybridomas were selected in hypoxanthine-
aminopterin-thymidine medium. Hybridomas of interest were
subcloned three times by limiting dilution, and grown in hypox-
anthine-thymidine (HT)
 
1
 
 medium supplemented with 10% (vol/
vol) fetal calf serum (Sebak, Suben, Austria). Class and subclass of
monoclonal antibodies were determined using an ELISA with
specific antisubclass antibodies (PharMingen, San Diego, CA).
Small scale protein G purification of antibodies was performed
using the Mab Trap GII kit (Pharmacia Biotech AB, Uppsala,
Sweden). F
 
ab
 
 fragment isolation was done using the Immu-
noPure
 
Ò
 
 F
 
ab
 
 preparation kit (Pierce Chemical Co., Rockford, IL).
 
ELISA Methods.
 
ELISA flat-bottomed microplates (Greiner,
Kremsmünster, Austria) were coated with 100 
 
m
 
l/well of the
membrane preparation from 
 
E. histolytica
 
 SFL-3 (10 
 
m
 
g/ml in
0.1% [wt/vol] ammonium bicarbonate, 0.05% [wt/vol] NaN
 
3
 
)
and dried at room temperature overnight. Hybridoma superna-
tants were added at different dilutions in PBS and incubated at
37
 
8
 
C for 1 h. Plates were washed five times, and bound antibod-
ies were detected with horseradish peroxidase–labeled anti–
mouse antibodies (Jackson ImmunoResearch Labs., Inc., West
Grove, PA) at a 1:1,000 dilution.
 
Immunoblotting.
 
Amebic membrane antigens were separated
by SDS-PAGE with 10% acrylamide gels (32), blotted onto ni-
trocellulose (Schleicher & Schüll, Dassel, Germany), and probed
with 1:100 dilutions of hybridoma supernatants in buffer G (50
mM sodium phosphate, 0.5% [vol/vol] Tween 20, 0.5% [wt/vol]
bovine serum albumin, and 0.05% [wt/vol] sodium azide, pH
7.5). Bound antibodies were detected with 
 
125
 
I-labeled sheep
anti–mouse antibodies (Amersham International, Buckingham-
shire, UK).
 
Metabolic Labeling and Extraction of Crude Glycolipids.
 
Metabolic
labeling was performed in a similar way as described by Prasad et
al. (19). In brief, SFL-3 trophozoites at a concentration of 2–5 
 
3
 
10
 
6
 
/ml of TYI-S-33 glucose- or phosphate-free medium were in-
cubated with either [
 
3
 
H]glucose (0.3 mCi/ml) or [
 
32
 
P]orthophos-
phate (0.5 mCi/ml) (both DuPont NEN, Cambridge, MA) for 3 h
at 36
 
8
 
C. The cells were washed with PBS three times at 4
 
8
 
C and
delipidated by extracting with five parts of chloroform/methanol
3:2 and one part of 4 mM MgCl
 
2
 
, next with five parts of chloro-
form/methanol/water 10:10:3 and one part of chloroform/meth-
anol 1:1, and afterwards with chloroform/methanol/water 10:10:3.
The crude glycolipids were then extracted with solvent E (water/
ethanol/diethylether/pyridine/ammonium hydroxide 15:15:5:1:
0.017). The insoluble residue was discarded, and the extract was
dried overnight in the vacuum, giving fraction E.
 
Immunoprecipitation of the Radiolabeled Antibody EH5 Binding
Antigen.
 
Crude glycolipids (fraction E) were resuspended in ice-
cold RIPA buffer (50 mM Tris/Cl, 150 mM NaCl, 1% [vol/vol]
NP-40, 0.5% [wt/vol] sodium deoxycholate, 0.1% [wt/vol] SDS,
pH 8.3; reference 30). Debris was removed by centrifugation, and
the supernatant was preadsorbed with protein G–Sepharose (Phar-
macia Biotech AB) for 1 h, centrifuged, and protein G–purified anti-
body EH5, isotype-matched control antibody BIP 1, or an amebiasis
patient’s serum at a dilution of 1:500 was added to the supernatant
and rotated end over end for 2 h at 4
 
8
 
C. Protein G–Sepharose was
added for 1 h, and then immune complexes were precipitated by
centrifugation, washed at least four times with RIPA buffer, re-
suspended in SDS-PAGE loading buffer, and loaded onto a 10%
SDS-PAGE gel. [
 
3
 
H]Glucose labeled molecules were visualized by
fluorography by treating the gels with EN
 
3
 
HANCE (DuPont
NEN) according to the supplier’s protocol. Gels containing 
 
32
 
P-
 
1
 
Abbreviations used in this paper:
 
 HT, hypoxanthine-thymidine; PI-PLC,
phosphatidylinositol-specific phospholipase C; TEM, transmission elec-
tron microscopy. 
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labeled molecules were directly exposed. All gels were exposed to
films at 
 
2
 
70
 
8
 
C.
 
Chemical and Enzymatic Cleavage of the EH5 Antigen, and Analy-
sis by Hydrophobic Chromatography.
 
Isolated fraction E from 10
 
7
 
E. histolytica
 
 SFL-3 trophozoites was treated with 100 
 
m
 
l of 40
mM trifluoroacetic acid for 8 min at 100
 
8
 
C for mild acid hydrol-
ysis (33). Alternatively, fraction E from 10
 
7
 
 trophozoites was
treated with 1 U phosphatidylinositol-specific phospholipase C
(PI-PLC)
 
1
 
 from 
 
Bacillus cereus
 
 (Boehringer Mannheim, Mann-
heim, Germany) in 0.1 M Tris/Cl, 0.1% (wt/vol) deoxycholate,
pH 7.4, overnight at 37
 
8
 
C. The cleaved preparations or the con-
trol without added PI-PLC was extracted with Triton X-114 (34)
and the products in the aqueous phase were analyzed (35) by
chromatography through phenyl-coupled Sepharose (Sigma
Chemical Co., St. Louis, MO). Cleaved samples were diluted in
1.8 ml of 0.1 M acetic acid, 0.1 M NaCl, and loaded onto a phe-
nyl-coupled Sepharose column with 2 ml bed volume. Three
fractions of 0.6 ml each were collected. The column was then se-
quentially washed with 2 
 
3
 
 0.6 ml of 0.1 M acetic acid, 2 
 
3
 
 0.6
ml of H
 
2
 
O, and 6 
 
3
 
 0.6 ml of solvent E (see above). All fractions
were dried in an atmosphere of nitrogen, resuspended in 10 
 
m
 
l of
H
 
2
 
O, and then 1-
 
m
 
l samples were dotted onto nitrocellulose and
antigen was detected with antibody EH5 and 
 
125
 
I-labeled sheep
anti–mouse antibodies.
 
Immunoaffinity Purification of the EH5 Antigen and Interaction with
Con A.
 
Protein G–purified antibody EH5 (Eurogentec, Sera-
ing, Belgium) was coupled to 3M Emphaze Biosupport Medium
(Pierce Chemical Co.) according to the instructions of the sup-
plier. Fraction E purified from 4 
 
3
 
 10
 
7
 
 
 
E. histolytica
 
 SFL-3 tro-
phozoites was dissolved in 10 ml of PBS with 0.05% (wt/vol)
deoxycholate and loaded on a 2-ml immunoaffinity column. The
column was washed with 20 ml of PBS, and the EH5 antigen was
eluted with 50 mM diethylamine, pH 11.5. Eluted antigen was
immediately transferred into PBS buffer using Microcon columns
(Amicon Inc., Beverly, MA). 1 
 
m
 
l of each fraction was dotted
onto nitrocellulose strips, and bound EH5 antigen was detected
with antibody EH5, which was visualized with alkaline phos-
phatase–coupled secondary antibodies. For the Con A binding
experiment, the strips were incubated with biotin-labeled Con A
(1:200 in buffer G, see above), and bound Con A was detected
with alkaline phosphatase–labeled streptavidin (1:500 in buffer G).
 
Agglutination Test.
 
The test was performed in a similar way to
that described by Torian et al. (36). 
 
E. histolytica SFL-3 trophozo-
ites (2–4 3 104/well) were added to 96-well flat-bottomed mi-
crotiter plates. Hybridoma supernatants of antibody EH5, protein
G–purified antibody EH5, Fab fragments from antibody EH5, iso-
type-matched negative control antibody BIP 1 directed against
the birch pollen allergen Bet v 1 (31), or HT medium as a control
was added to the wells. Plates were further incubated at 378C.
Photographs were taken before and 15 and 60 min after the addi-
tion of antibodies and controls.
Indirect Immunofluorescence of E. histolytica. Growing HM-1:IMSS
trophozoites were washed with PBS at 378C, transferred to a
coverslip in a 24-mm petri dish, and incubated at 378C for 10
min to promote attachment. PBS was removed and coverslips
were incubated in 3.7% (wt/vol) paraformaldehyde for 15 min at
room temperature. One part of the samples was placed in metha-
nol at 2208C for 3 min (treatment A), and the rest were treated
by 0.25% (vol/vol) of Triton X-100 in PBS for 3 min (treatment
B). Coverslips were washed with PBS, incubated in the presence
of 50 mM NH4Cl for 30 min, and then in PBS containing 1%
(wt/vol) of nonfat dry milk for 30 min. For in situ epifluorescent
labeling of monoclonal antibodies, coverslips were incubated
with 1:100 diluted monoclonal antibodies (purified over protein
G column) for 1 h. After two washes with PBS, samples were in-
cubated for 30 min in a 1:200 dilution in PBS of rhodamine or
FITC-labeled rabbit anti–mouse antibodies (Sigma Chemical
Co.), which had been preadsorbed with trophozoites as previ-
ously described (37). The preparations were further incubated in
PBS containing 1% bovine serum albumin for 30 min at room
temperature, briefly washed in PBS, and mounted on a glass slide
with 70% (vol/vol) glycerol in PBS.
Confocal Microscopy. Fluorescent samples were examined on a
confocal laser scanning microscope (DIAPLAN; Leica, Heidel-
berg, Germany) equipped with a 363 objective. Rhodamine-
labeled samples were visualized using a high pass R6590 filter af-
ter excitation at 568 nm. Observations were performed in 10
planes from the bottom to the top of each cell. The distance be-
tween scanning planes was 0.5 mm. Three dimensional recon-
struction of serial confocal sections was performed with the
CLSM-Leica software. Photographs were taken on Kodak T-max
400 film (Eastman Kodak Co., Rochester, NY) using a 35-mm
camera mounted on a Polaroid Freeze-Frame video monitor.
Transmission Electron Microscopy (TEM) and Immunogold Label-
ing. Growing trophozoites (107) from E. histolytica strain HM-1:
IMSS were harvested by centrifugation at 700 g for 5 min and
washed in PBS. Cells were fixed with 4% paraformaldehyde and
0.2% glutaraldehyde in 100 mM Hepes, pH 6.9, for 1 h at 48C.
After one wash with the same buffer, trophozoites were embed-
ded in 10% gelatin and then slowly centrifuged. The pellet was
solidified on ice and cut in 1-mm3 pieces which were infused in
1.7 M sucrose and 15% polyvinylpyrrolidone (10,000 mol wt) for
varying amounts of time, from 2 h to overnight. The samples
were mounted on holder pins and frozen by rapid immersion in
liquid nitrogen or in liquid propane. Thin sections were cut at
21208C using a diamond knife on an FCS cryosystem (Reichert,
Vienna, Austria). Grids were treated with drops of the following
reagents: 50 mM NH4Cl in PBS (10 min), 1% (wt/vol) bovine
serum albumin in PBS (5 min), purified antibody EH5, diluted 1:
100 in 1% bovine serum albumin in PBS (1 h), PBS (3 washes, 5
min each), anti–mouse IgG 1 IgM antibodies conjugated with
10-nm gold particles (British Biocell International, Cardiff, UK)
diluted in 0.01% (wt/vol) fish skin gelatin (Sigma Chemical Co.)
in PBS (30–40 min), PBS (1 min), and distilled water (3 washes, 1
min each). Samples on the grids were then fixed with 1% glu-
taraldehyde in 100 mM cacodylate, pH 7.4 (2 min), rinsed with
distilled water, and embedded in 1% (wt/vol) methylcellulose and
0.3% (wt/vol) uranyl acetate. Sections were observed with an
electron microscope (CM12; Philips, Eindhoven, Netherlands)
operating at 60 kV.
Passive Immunization of SCID Mice. CB-17 SCID mice (The
Jackson Laboratory, Bar Harbor, ME) were treated according to
the method of Cieslak et al. (38). Each immunized animal re-
ceived 200 ml of antibody EH5 (1 mg/ml; n 5 12) or isotype-
matched control monoclonal antibody HDP-1 (1 mg/ml; n 5 6)
intraperitoneally 24 h before intrahepatic challenge. All 18 pas-
sively immunized SCID mice, and 7 control SCID mice which
received no antibody, underwent direct hepatic inoculation. The
animals were fasted for 24 h and subsequently anesthetized by in-
tramuscular application of a combination of ketamine hydrochlo-
ride and xylazine. Laparotomy was performed by a vertical inci-
sion of z1 cm to visualize the liver. E. histolytica HM-1:IMSS
trophozoites (106) in a volume of 100 ml were injected into the
left liver lobe. Peritoneum and abdominal wall were closed by
catgut sutures and the skin was closed using clips. After 7 d, ani-
mals were killed and the liver was entirely removed, sectioned,1560 Protection against Invasive Amebiasis by One Monoclonal Antibody
and any abscess detected was resected and weighed separately.
The percentage of liver abscessed was calculated as the weight of
the abscess divided by the liver weight before abscess removal.
Results
Antibody Production. Using a membrane preparation of
E. histolytica SFL-3 as a mixture of antigens, a panel of eight
monoclonal antibodies (EH1 to EH8) was raised. All of
these antibodies bound to amebic membrane antigens in
ELISA and immunoblot assays. This report deals exclu-
sively with antibody EH5 and the EH5 antigen. The EH5
antibody belongs to the IgG1 subclass as determined by
ELISA.
Test of Antibodies with Membrane Preparations of Different E.
histolytica and E. dispar Strains. Preliminary ELISA tests had
shown that antibody EH5 was able to discriminate between
E. histolytica and E. dispar (data not shown). Fig. 1 shows
the immunoblot results obtained with membrane prepara-
tions from different xenically and axenically grown E. his-
tolytica and E. dispar strains using antibody EH5. In addi-
tion, a membrane preparation from Trichomonas vaginalis,
another protist parasite which is only distantly related to E.
histolytica and E. dispar, was prepared and included. The
immunoblots show strong reactivity for all E. histolytica
strains of antigens migrating as a polydisperse band, whereas
E. dispar bound to antibody EH5 weakly, and T. vaginalis
hardly at all. In addition, the signals were stronger when
the amebas had been grown axenically.
Characterization of the Antigen Recognized by Antibody
EH5. The patterns in the immunoblots resembled pat-
terns that had been previously observed for lipophospho-
glycan antigens (19, 20). To test whether the EH5 antigen
copurified with lipophosphoglycans, whole E. histolytica
SFL-3 trophozoites were delipidated, and glycolipids (frac-
tion E) were extracted. An immunoblot of the fractions
demonstrated that most of the EH5 antigen was extracted
into fraction E (results not shown). To identify some of the
components present in the EH5 antigen, a metabolic label-
ing experiment was performed. SFL-3 trophozoites were
either labeled with [3H]glucose or [32P]orthophosphate.
The radiolabeled amebas were washed and delipidated, and
fraction E was obtained and resuspended in RIPA buffer.
The preparation was preadsorbed with protein G–Sepharose
to remove unspecific complexes. The samples were then
incubated either with antibody EH5, with isotype-matched
control antibody BIP 1 (31), or as a positive control with
the serum from an amebiasis patient in a 1:500 dilution.
Immune complexes were bound to protein G–Sepharose,
precipitated, and analyzed by SDS-PAGE followed by flu-
orography or autoradiography. Fig. 2 A shows the results
for the labeling with [3H]glucose. Only the patient’s serum
(Fig. 2 A, lane 4) and antibody EH5 (Fig. 2 A, lane 2), but
not the control antibody BIP 1 (Fig. 2 A, lane 3), precipi-
tated the antigen. This showed that radiolabeled glucose
was incorporated into the EH5 antigen. Fig. 2 B shows the
results for the labeling with [32P]orthophosphate. Whole
amebas were labeled very heavily (data not shown). Again,
antibody EH5 (Fig. 2 B, lane 1) and the patient’s serum
(Fig. 2 B, lane 2), but not the control antibody BIP 1 (Fig.
2 B, lane 3) precipitated a phosphate-labeled antigen. Thus,
EH5 antigen also incorporated radiolabeled phosphate.
To test whether these phosphates were forming acid-
labile diester bonds, fraction E from E. histolytica SFL-3 tro-
phozoites was digested for 8 min at 1008C in 40 mM triflu-
oroacetic acid. The products were analyzed by hydrophobic
chromatography on phenyl-coupled Sepharose. The undi-
gested EH5 antigen in fraction E eluted over a large range
(Fig. 3, lane B), mild acid digestion reduced the binding of
the EH5 antibody, and the partially digested EH5 antigen
eluted only in the hydrophobic region (Fig. 3, lane A), in
agreement with the degradation of the hydrophilic parts of
the molecules.
Figure 1. Immunoblot: mem-
brane preparations from axeni-
cally cultured E. histolytica HM-
1:IMSS (1), 200:NIH (2), HK-9
(3), and SFL-3 (4), xenically
grown E. histolytica SFL-3 (5),
axenically grown E. dispar
SAW760 (6), xenically grown E.
dispar SAW142 (7), and axeni-
cally grown T. vaginalis (8) were
separated by SDS-PAGE, blotted
onto nitrocellulose, and probed
with a 1:100 dilution of hybri-
doma supernatant from antibody
EH5 (A lanes) or buffer only (B
lanes). Bound antibodies were
detected with 125I-labeled sheep
anti–mouse antibodies.
Figure 2. Metabolic labeling experiments. (A) Labeling with [3H]glu-
cose. Lane 1, total PBS washed amebas; lane 2, fraction E, immunopre-
cipitated with antibody EH5; lane 3, fraction E, immunoprecipitated with
isotype-matched control antibody BIP 1; lane 4, fraction E, immunopre-
cipitated with amebiasis patient’s serum. (B) Labeling with [32P]ortho-
phosphate. Lane 1, fraction E immunoprecipitated with antibody EH5;
lane 2, fraction E immunoprecipitated with amebiasis patient’s serum;
lane 3, fraction E immunoprecipitated with control antibody BIP 1. At
the left side, molecular masses from a protein marker are given for better
orientation. However, these cannot serve as size markers for molecules
such as lipophosphoglycans.1561 Marinets et al.
Fraction E was also subjected to treatment with PI-PLC,
followed by Triton X-114 extraction and hydrophobic
chromatography (Fig. 3, lanes C and D). This time, the mi-
gration of the EH5 antigen shifted towards a more hydro-
philic region, in agreement with the partial cleavage of hy-
drophobic glycoinositol phospholipid (GPI) membrane
anchors from the EH5 antigen. Although we do not yet know
the exact chemical structure of the EH5 antigen, the results
showed that it could be classified as a lipophosphoglycan.
Binding of Con A to the EH5 Antigen and Agglutination of
Trophozoites by the EH5 Antibody. Recently, it was shown
that components in fraction E from E. histolytica bound to
Con A, and therefore were likely to contain terminal
mannose residues (23). With a new preparation of protein
G–purified EH5 antibody, we were able to immunoaffinity
purify the EH5 antigen as described above. Alkaline elution
conditions were used, instead of the more common acidic
conditions, to protect the antigen from partial degradation.
Fig. 3, lane E, shows dotted fractions from the immunoaf-
finity column that were probed with antibody EH5. The
antigen eluted as a broad peak. In Fig. 3, lane F, the same
fractions were dotted onto nitrocellulose, incubated with
biotin-labeled Con A, and bound Con A was detected
with alkaline phosphatase–labeled streptavidin. Three of
the four fractions eluted from the affinity column and con-
taining EH5 antigen also bound to Con A, and one of the
fractions did not bind. This showed, on the one hand, that
the EH5 antigen was chemically heterogeneous, but on the
other hand, that a large portion of the EH5 antigen bound
to Con A.
If the EH5 antigen, or at least a significant portion of it,
was able to bind to Con A, which is known to agglutinate
preferentially pathogenic amebas (39, 40), then the EH5
antibody should also be able to agglutinate E. histolytica tro-
phozoites. To test this, E. histolytica SFL-3 trophozoites (2–
4 3 104/well) were used in an agglutination experiment
(Fig. 4) along the lines described for the agglutination by an
antibody against a 96-kD antigen (36). Fig. 4 A shows the
amebas 1 h after addition of only HT hybridoma medium,
whereas  B shows the results after addition of isotype-
matched control antibody BIP 1. Fig. 4, C and D, shows
the amebas 15 and 60 min after addition of antibody EH5
supernatant, whereas E and F show the effect of purified
antibody EH5 after 15 and 60 min. The agglutination pro-
cess began z15 min after addition of antibody EH5, and
after 1 h the amebas were strongly agglutinated. No agglu-
tination was observed when isolated monomeric Fab frag-
ments from antibody EH5 were added (data not shown).
Confocal Immunofluorescence Using Antibody EH5. To de-
termine the cellular localization of the antigen recognized
by the EH5 antibody in the amebas by independent means,
immunolocalization experiments on the light and electron
microscopic levels were performed. First, trophozoites
were fixed and incubated with antibody EH5. Two differ-
ent methods of fixation and permeabilization were used
(see Materials and Methods). In method A, amebas were
incubated in the presence of methanol. After labeling, tro-
phozoites were analyzed by laser confocal microscopy (Fig.
5 A) at four different optical planes and revealed a labeling
of the entire surface of the amebas. When fixed trophozo-
ites were permeabilized by using Triton X-100 to solubi-
Figure 3. Sensitivity of the EH5 antigen towards mild acid digestion
(lanes A and B), and towards PI-PLC (lanes C and D) and binding to Con
A (lanes E and F). For lanes A–D, fractions were chromatographed
through phenyl-coupled Sepharose, eluted fractions were dotted onto ni-
trocellulose and reacted with antibody EH5, and bound antibody was de-
tected with iodine-labeled sheep anti–mouse antibodies; lane A, mild acid
digestion; lane B, undigested control; lane C, PI-PLC digestion; lane D,
control incubated in PI-PLC buffer only. For lanes E and F, eluted frac-
tions from immunoaffinity column (E) tested with antibody EH5, bound
antibodies detected with alkaline phosphatase–coupled anti–mouse anti-
bodies; (F) tested with biotin-labeled Con A, bound Con A detected with
alkaline phosphatase–coupled streptavidin.
Figure 4. Agglutination test:
E. histolytica trophozoites in HT
medium after 1 h of incubation
(A); with isotype-matched con-
trol antibody BIP 1 after 1 h of
incubation (B); with supernatant
of antibody EH5 after 15 min of
incubation (C); the same after 1 h
of incubation (D); with protein
G–purified antibody EH5 after
15 min of incubation (E); and the
same after 1 h of incubation (F).1562 Protection against Invasive Amebiasis by One Monoclonal Antibody
lize the membrane lipids (method B), labeling with anti-
body EH5 and confocal microscopy (Fig. 5 B) revealed
labeling of the periplasmic membrane as well as internal
vesicle membranes. Secondary antibodies used alone in
control experiments did not label the amebas (results not
shown).
TEM and Immunolabeling. Cellular localization of the
EH5 antigen on the ultrastructural level was examined by
TEM and immunogold labeling. Growing trophozoites
were fixed and treated for TEM using a protocol specifi-
cally adapted for E. histolytica (see Materials and Methods)
to obtain maximal preservation of antigenic structure. The
resulting pictures indicate a localization of the EH5 antigen
primarily in association with the membranes. On the
plasma membrane (Fig. 6, a and b), gold particles were ob-
served on the outward face, whereas in the internal mem-
brane-bound structures (Fig. 6 a), the gold particles ap-
peared to be localized preferentially on the inner face of the
membranes.
Passive Immunization Study in SCID Mice. With the im-
munolocalization studies showing a strong expression of the
EH5 antigen on the surface of E. histolytica, it was interest-
ing to get some information on whether the antigen might
be a possible vaccine candidate. To address this question,
we chose the SCID mouse model because it is well-suited
for passive immunization studies. Treated mice received a
single dose of 200 mg of either isotype-matched control
monoclonal antibody HDP-1, antibody EH5, or no treat-
Figure 5. Localization of the antigen binding
to antibody EH5 in E. histolytica trophozoites by
indirect immunofluorescence using confocal mi-
croscopy. (A) Amebas treated with methanol; (B)
amebas treated with Triton X-100 for stronger
permeabilization. Planes a, b, and c are horizontal
planes, and plane d is a vertical plane through the
middle of the ameba.1563 Marinets et al.
ment 24 h before intrahepatic challenge. 7 d after chal-
lenge, the mice were killed and examined for liver abscess
formation, and abscess sizes were determined.
All control SCID mice (7 out of 7) and all SCID mice
passively immunized with the isotype-matched control
monoclonal antibody HDP-1 (6 out of 6) had amebic liver
abscesses (Table 1), with a mean abscess size of 16 6 7% of
the liver abscessed in control mice, and 15 6 6% of the
liver abscessed in HDP-1 treated mice. In contrast, only 1
out of 12 mice receiving EH5 monoclonal antibody devel-
oped an amebic liver abscess, and the abscess size in this
SCID mouse was smaller (9% of the liver abscessed). The
difference in the number of mice developing an amebic
liver abscess between HDP-1 immunized SCID mice and
SCID mice receiving antibody EH5 was highly significant
(P ,0.0005).
Discussion
In this study, monoclonal antibodies were raised against a
membrane preparation from E. histolytica to enable us to
study surface structures of this parasite, which might be
vaccine candidates in the future, and to identify molecules
preferentially found on the surface of pathogenic amebas
which might be important in the molecular cross-talk with
the host.
The monoclonal antibody technology was chosen with
the aim of studying defined antigens, and, as an important
second criterion, of looking for antibodies with selective
binding to E. histolytica as compared to E. dispar. Antibody
EH5 fulfilled these criteria in the best way and was selected
for further study. Both immunoblot and ELISA data
showed a large difference in the binding of the EH5 anti-
body between the pathogenic and nonpathogenic species.
It remains to be tested if this difference can be exploited for
diagnostic purposes.
The polydisperse bands obtained in immunoblots using
antibody EH5 resembled those obtained from the previ-
ously described monoclonal antibodies 2D7.10, described
by Bhattacharya and colleagues (17, 19), and CC 8.6, taken
from our laboratory (20). All three antibodies bind to lipo-
phosphoglycan antigens. However, the epitopes recognized
seem to be different, because the three antibodies show
clear differences in binding to different strains of E. histolyt-
ica. 2D7.10 binds to an antigen which is almost completely
downregulated by the presence of bacteria (21), while EH5
showed much smaller differences in binding between xenic
or axenic cultures. The CC 8.6 antibody bound only
weakly to strain 200:NIH (20), whereas EH5 exhibited
strong binding to 200:NIH (see Fig. 1). Taken together,
the expression of certain epitopes of the amebic lipophos-
phoglycans appears to display strain differences and to be
dependent on culture conditions.
The localization of the EH5 antigen was studied by con-
focal immunofluorescence microscopy and immunogold
labeling observed by TEM. The confocal images showed
that the labeling on the surface was very intense, but also
extended to vesicular structures when stronger permeabili-
zation conditions were applied. The immunogold labeling
gave an interpretation to these findings; the EH5 antigen
could be directly visualized on the outer face of the plasma
membrane and the inner face of what appeared to be a ve-
sicular membrane. Thus, the EH5 lipophosphoglycan anti-
gen forms not only a surface coat, but also appears in the
Figure 6. Cryosection immunogold staining of trophozoites stained
with antibody EH5, showing two areas of the trophozoite with (a) or
without (b) internal membrane-bound vesicle (bar 5 0.5 mm).
Table 1. Protection of SCID Mice from Amebic Liver Abscess by Passive Immunization with Anti-lipophosphoglycan Monoclonal
Antibody EH5
Vaccine group
No. of SCID mice with liver abscess/
No. of SCID mice challenged Percentage protected
Percentage of liver abscessed 
in nonprotected mice
mean 6 SD
Nonimmunized 7/7 0.0 16 6 4
HDP-1 (control) immunized 6/6 0.0 15 6 6
EH5 immunized 1/12 91.7 (P ,0.0005)* 9
*Significant difference from control immunized group as determined by Fisher’s exact test.1564 Protection against Invasive Amebiasis by One Monoclonal Antibody
amebas in inverted vesicles. This demonstrates the difficulty
of clearly defining surface localization in this dynamic or-
ganism.
The immunoaffinity-purified EH5 antigen bound to
Con A in a dot-blot experiment with the exception of one
of the antibody-positive fractions from the affinity column.
This result pointed again to a significant chemical hetero-
geneity of the EH5 antigen. More importantly, the prefer-
ential agglutination of pathogenic amebas (39, 40) by Con
A can be explained at least in part by the binding of Con A
to the lipophosphoglycan-like antigen recognized by the
EH5 antibody. In agreement with this explanation, the
EH5 antibody strongly agglutinated E. histolytica trophozo-
ites. However, it is clear that other structures such as glyco-
proteins on the amebal surface are also likely to play a role
in the agglutination by Con A. Also, it is not known if Con
A bound to a lipophosphoglycan is capped by the amebas.
Recently, it was shown, with polyclonal antibodies to
defined regions of the galactose- and N-acetylgalactosamine–
inhibitable lectin, that, depending on the epitopes recog-
nized, passive immunization can either protect SCID mice
from amebic liver abscess or it can exacerbate the disease
(13). Passive immunization with the lipophosphoglycan-
specific antibody EH5 conferred highly significant protec-
tion against amebic liver abscess. This is the first report on a
single monoclonal antibody with this ability, and the first
report relating protection to a glycan epitope.
Significantly, the SFL-3 strain, against which the anti-
bodies were raised, and the HM-1:IMSS challenge strain
were different, so the protection is not strictly limited to
one strain. Antibody EH5 bound to all E. histolytica strains
that we were able to test; however, antibody EH5 may fail
to be protective against some strains of E. histolytica or in
other strains of mice. In the future, it will be very interest-
ing to examine the structure of the EH5 epitope, look for
ways to synthesize it in vitro, and test whether such a struc-
ture may be a component for active immunization.
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